Trial
NCT04634669
Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Axsome Therapeutics, Inc.
Collaborators
—
Condition
Treatment Resistant Depression
Intervention
AXS-05 (dextromethorphan-bupropion)
Why stopped
This study was terminated once overall program objectives were met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-28